Patents by Inventor Tahera Iqbal Ansari

Tahera Iqbal Ansari has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11473048
    Abstract: A bioreactor including a housing, a first fluid dispenser and a second fluid dispenser. The bioreactor is configured to receive a scaffold mounted within the housing with the first and second fluid dispensers being positioned to apply respective first and second fluids to at least two different regions of a mounted scaffold.
    Type: Grant
    Filed: July 25, 2017
    Date of Patent: October 18, 2022
    Assignee: VIDEREGEN LIMITED
    Inventor: Tahera Iqbal Ansari
  • Publication number: 20190177680
    Abstract: A bioreactor including a housing, a first fluid dispenser and a second fluid dispenser. The bioreactor is configured to receive a scaffold mounted within the housing with the first and second fluid dispensers being positioned to apply respective first and second fluids to at least two different regions of a mounted scaffold.
    Type: Application
    Filed: July 25, 2017
    Publication date: June 13, 2019
    Applicant: NORTHWICK PARK INSTITUTE FOR MEDICAL RESEARCH LTD
    Inventor: Tahera Iqbal ANSARI
  • Publication number: 20190117840
    Abstract: This invention provides cross-linked dermal scaffolds, dermal replacements and methods for making the same in which particles or granules of biological tissue are cross-linked with quercetin and/or genipin. The cross-linked tissue is prepared by decellularising biological tissue and cross-linking the biological tissue with quercetin and/or genipin, with the tissue being grown into particles or granules either before or after cross-linking.
    Type: Application
    Filed: March 30, 2017
    Publication date: April 25, 2019
    Inventors: Tahera Iqbal ANSARI, Karin GRECO
  • Patent number: 10226547
    Abstract: The invention relates to an implant derived from intestinal tissue and to an improved method for producing an implant from intestinal tissue. According to the invention, intestinal tissue comprising a tubular segment of intestine with at least part of its associated vasculature intact is processed by: perfusing the vasculature through a vessel thereof with at least one decellularizing medium; and separately perfusing the tubular segment of intestine through its lumen with at least one decellularizing medium. The new method greatly improves tissue processing as compared with the methods previously known in the art, in which decellularization solutions were perfused into the tissue via the vasculature only, relying on diffusion to decellularize and purify the small bowel tissue.
    Type: Grant
    Filed: July 16, 2013
    Date of Patent: March 12, 2019
    Assignee: VIDEGREN LIMITED
    Inventors: Paul David Sibbons, Tahera Iqbal Ansari
  • Patent number: 9950095
    Abstract: The invention provides a method for producing an implant from interstitial, connective or supporting tissue, the method comprising at least one step of perfusing the tissue with at least one decellularization medium under negative pressure applied for substantially the whole time period of the perfusion.
    Type: Grant
    Filed: June 16, 2014
    Date of Patent: April 24, 2018
    Assignee: Videregen Limited
    Inventors: Tahera Iqbal Ansari, Paul David Sibbons
  • Publication number: 20160095956
    Abstract: The invention provides a method for producing an implant from interstitial, connective or supporting tissue, the method comprising at least one step of perfusing the tissue with at least one decellularisation medium under negative pressure applied for substantially the whole time period of the perfusion.
    Type: Application
    Filed: June 16, 2014
    Publication date: April 7, 2016
    Applicant: VIDEREGEN LIMITED
    Inventors: Tahera Iqbal ANSARI, Paul David SIBBONS
  • Publication number: 20150190548
    Abstract: The invention relates to an implant derived from intestinal tissue and to an improved method for producing an implant from intestinal tissue. According to the invention, intestinal tissue comprising a tubular segment of intestine with at least part of its associated vasculature intact is processed by: perfusing the vasculature through a vessel thereof with at least one decellularising medium; and separately perfusing the tubular segment of intestine through its lumen with at least one decellularising medium. The new method greatly improves tissue processing as compared with the methods previously known in the art, in which decellularisation solutions were perfused into the tissue via the vasculature only, relying on diffusion to decellularise and purify the small bowel tissue.
    Type: Application
    Filed: July 16, 2013
    Publication date: July 9, 2015
    Applicant: Videregen Limited
    Inventors: Paul David Sibbons, Tahera Iqbal Ansari